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Abstract
Ecological and evolutionary concepts have been widely adopted to understand host–
pathogen dynamics, and more recently, integrated into wildlife disease management. 
Cancer is a ubiquitous disease that affects most metazoan species; however, the 
role of oncogenic phenomena in eco-evolutionary processes and its implications for 
wildlife management and conservation remains undeveloped. Despite the pervasive 
nature of cancer across taxa, our ability to detect its occurrence, progression and 
prevalence in wildlife populations is constrained due to logistic and diagnostic limita-
tions, which suggests that most cancers in the wild are unreported and understudied. 
Nevertheless, an increasing number of virus-associated and directly transmissible 
cancers in terrestrial and aquatic environments have been detected. Furthermore, 
anthropogenic activities and sudden environmental changes are increasingly associ-
ated with cancer incidence in wildlife. This highlights the need to upscale surveillance 
efforts, collection of critical data and developing novel approaches for studying the 
emergence and evolution of cancers in the wild. Here, we discuss the relevance of 
malignant cells as important agents of selection and offer a holistic framework to 
understand the interplay of ecological, epidemiological and evolutionary dynamics 
of cancer in wildlife. We use a directly transmissible cancer (devil facial tumour dis-
ease) as a model system to reveal the potential evolutionary dynamics and broader 
ecological effects of cancer epidemics in wildlife. We provide further examples of 
tumour–host interactions and trade-offs that may lead to changes in life histories, 
and epidemiological and population dynamics. Within this framework, we explore im-
munological strategies at the individual level as well as transgenerational adaptations 
at the population level. Then, we highlight the need to integrate multiple disciplines 
to undertake comparative cancer research at the human–domestic–wildlife interface 
and their environments. Finally, we suggest strategies for screening cancer incidence 
in wildlife and discuss how to integrate ecological and evolutionary concepts in the 
management of current and future cancer epizootics.
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1  | INTRODUC TION
Over the last two decades, significant efforts have been made to 
incorporate ecological and evolutionary principles to better under-
stand the dynamics of wildlife diseases and their impact on wild 
populations (Galvani, 2003; Tompkins, Dunn, Smith, & Telfer, 2011; 
Vander Wal et al., 2014). The reciprocal interactions between host 
and pathogens are in many ways analogous to the interplay of eco-
logical and evolutionary processes between species and their en-
vironment. Thus, the eco-evolutionary processes and feedbacks in 
emerging host–pathogen systems are currently considered key in 
epidemiology and disease management (Brosi, Delaplane, Boots, & 
Roode, 2017; Coen & Bishop, 2015; Grenfell et al., 2004). Cancer is a 
disease that evolved with the transition to multicellularity (Aktipis & 
Nesse, 2013) and therefore affects most metazoans on earth. It cor-
responds to a family of potentially lethal pathologies in which normal 
cells lose their typical cooperative behaviour, proliferate, spread and 
hence become malignant. Despite the ubiquitous nature of cancers 
in wildlife, the role of the oncobiota (i.e. oncogenic phenomena from 
precancerous lesions to metastatic cancer, Thomas et al., 2017) 
in ecological and evolutionary processes has been historically ne-
glected (but see Thomas et al., 2017; Vittecoq et al., 2013) and its ap-
plications for wildlife management and conservation remain mostly 
in their infancy. Given that cancer is an evolving disease where the 
ecological context of tumour–host interactions is of paramount rel-
evance for disease progression and immunological responses, evo-
lutionary principles have recently been used in oncology as a novel 
approach for developing therapeutic treatments (Enriquez-Navas, 
Wojtkowiak, & Gatenby, 2015; Willyard, 2016; Zhang, Cunningham, 
Brown, & Gatenby, 2017).
Oncogenic phenomena can act as important agents of selection 
by having differential effects on the survival, life history, reproduc-
tive success and fitness of hosts (Thomas et al., 2017, 2018; Ujvari, 
Beckmann, et al., 2016). These processes can shape phenotypic, ge-
netic and epigenetic variance across individuals, populations and spe-
cies. Carcinogenesis is a complex process that depends on trade-offs 
at the cellular and organismal levels, and, in turn, these trade-offs in-
teract with individuals and species, and hence ecosystems (Jacqueline 
et al., 2017; Pesavento, Agnew, Keel, & Woolard, 2018; Wu, Wang, 
Ling, & Lu, 2016). Thus, cancer should not be studied in isolation but 
as an interacting force of selection between species and their chang-
ing environments. Furthermore, in a century characterized by rapid 
environmental changes, species are increasingly facing additional eco-
logical and immunological trade-offs that in turn may increase cancer 
risk (Jacqueline et al., 2017). Unravelling the synergistic effects of en-
vironmental degradation, ecological and evolutionary processes, and 
susceptibility to cancer is nonetheless a complex task. Recognizing 
these complexities using a multidisciplinary approach will permit the 
understanding of important concepts underpinning cancer emergence 
and evolution and at the same time identify novel and integrative 
frameworks for managing cancers in wildlife.
The misleading assumption that cancers in wildlife are rare stems 
from the logistic difficulties in detecting their occurrence and mon-
itoring their prevalence: in most cases, afflicted hosts are preyed 
upon or die unseen (Vittecoq et al., 2013). This suggests that most 
cancers in the wild are unreported and understudied. In addition, 
infectious agents are now well recognized as important drivers of 
cancer causation. For example, 15%–20% of all cancers in humans 
have been associated with a direct infectious origin (i.e. oncoviruses) 
(Alizon, Bravo, Farrell, & Roberts, 2019; Ewald & Swain Ewald, 2015). 
There is considerable evidence that environmental factors are a 
major contributor to cancer risk. Anthropogenic activities such as ur-
banization, chemical contamination and knock-on effects from rapid 
environmental changes have been associated with high cancer prev-
alence in wildlife and a lack of upregulation of anticancer defence 
mechanisms in these carcinogenic habitats (Giraudeau, Sepp, Ujvari, 
Ewald, & Thomas, 2018; Giraudeau et al., 2020; Pesavento et al., 
2018; Sepp, Ujvari, Ewald, Thomas, & Giraudeau, 2019). However, 
only recently has cancer been considered a disease of conservation 
concern (McAloose & Newton, 2009) and transmissible cancers 
regarded as a new modality of infectious disease (Metzger & Goff, 
2016). The increasing number of virus-associated and directly trans-
mitted cancers detected in wildlife (Table 1), particularly for species 
already endangered (Gulland, Trupkiewicz, Spraker, & Lowenstine, 
1996; James et al., 2019; McCallum et al., 2009; Williams et al., 1994; 
Woolford et al., 2008), demonstrates the urgent need for develop-
ing a holistic framework for studying oncogenic phenomena in the 
wild. Studying patterns of emergence, tumour–host interactions and 
evolutionary processes between hosts and malignant cells will also 
provide new insights into our understanding of how cancer defence 
mechanisms arise and evolve in nature (Nunney, 2013).
2  | IMMUNE RESPONSES TO INFEC TIOUS 
C ANCERS IN WILDLIFE
Infectious cancers can be broadly grouped into two categories: di-
rectly transmissible cancers, where the infectious agent is the cancer 
cell itself (Ostrander, Davis, & Ostrander, 2016), and indirectly trans-
missible cancers, where the infectious agent is a pathogen such as 
a virus that induces cancer formation (Ewald & Swain Ewald, 2015). 
Although there are similarities in terms of host immune responses, 
the interaction between these types of infectious cancers with the 
host immune system is multifaceted and in some cases cancer-spe-
cific, as described in detail below. The vertebrate immune system 
consists of two arms: the innate immune system, which functions 
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to induce systemic inflammation and nonspecific immune responses 
(Hato & Dagher, 2015), and the adaptive immune system, which ex-
erts specific immune responses against pathogens or tumour-associ-
ated antigens (Cooper & Alder, 2006). Understanding the interaction 
between infectious cancers and the host immune system is key to 
developing effective disease management strategies.
2.1 | Directly transmissible cancers
There are nine known directly transmissible cancers: one in domes-
tic dogs (CTVT; Murgia, Pritchard, Kim, Fassati, & Weiss, 2006), two 
independently evolved transmissible tumours in Tasmanian devils 
(Sarcophilus harrisii) (devil facial tumour disease [DFTD] and devil 
facial tumour 2 [DFT2]) (Pearse & Swift, 2006; Pye, Pemberton, 
et al., 2016) and six lineages of transmissible neoplasia circulating 
in six species of marine bivalves (Metzger et al., 2016; Yonemitsu 
et al., 2019). In CTVT and DFTD, immune evasion is at least partially 
achieved through downregulation of the major histocompatibility 
complex (MHC) proteins from the tumour cells' surface (Siddle et al., 
2013; Yang, Chandler, & Dunne-Anway, 1987). MHC is a highly poly-
morphic group of proteins which label infected or cancerous cells 
for immune destruction by T cells (Wieczorek et al., 2017). Thus, re-
moval of MHC from the cell surface hides the cancer from host im-
mune cells and prevents clearance by the adaptive immune system. 
It has been demonstrated in both CTVT and DFTD that restoration 
of MHC to the cell surface can result in specific immune responses 
against the tumour cells (Hsiao et al., 2008; Tovar et al., 2017). In 
contrast, DFT2 expresses MHC on the cell surface (Caldwell et al., 
2018); however, recent evidence suggests that DFT2 is currently los-
ing its MHC-I expression from the cell surface (Ong, Lyons, Woods, 
& Flies, 2019), thereby enhancing its transmissibility potential.
Major histocompatibility complex polymorphism enables im-
mune recognition of many pathogens, ensuring species survival in 
the face of epidemics (Savage & Zamudio, 2011; Sommer, 2005). 
Low polymorphism has been linked to reduced species fitness and 
a lower ability to recognize novel pathogens (Belasen, Bletz, Leite, 
Toledo, & James, 2019; Maibach & Vigilant, 2019), although this 
is not always the case (Castro-Prieto, Wachter, & Sommer, 2010). 
Low genetic diversity in Tasmanian devil populations, particularly 
in MHC genes (Cheng et al., 2012; Morris, Austin, & Belov, 2013; 
Siddle, Kreiss, et al., 2007), may have reduced the ability of the dev-
il's immune system to distinguish self from non-self-malignant cells, 
facilitating the emergence of transmissible tumours (Caldwell et al., 
2018). These mechanisms of emergence have been implicated in 
both DFTD and CTVT (Murchison et al., 2014; Siddle, Sanderson, 
Sanderson, & Belov, 2007), although the absence of MHC molecules 
from circulating tumours indicates that the host immune system has 
exerted pressure on the cancer cells during their evolution, as has 
been observed in single-organism cancer (McGranahan et al., 2017). 
The immune responses seen in DFTD, DFT2 and CTVT hosts are 
largely tumour-specific, indicating activation of the adaptive immune 
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Hamede, et al., 2016; Tovar et al., 2017). It is unclear whether marine 
bivalves raise any immune response against their transmissible neo-
plasia, although the lack of an adaptive immune system and MHC in 
invertebrates suggests that they may be more vulnerable to direct 
transmission of cancerous cell lines (Gestal et al., 2008; Metzger 
& Goff, 2016). At least until stronger anticancer defences (resis-
tance) are selected for in these species, individuals could potentially 
achieve higher fitness by increasing their tolerance to cancer, that 
is surviving despite the presence of tumours (Thomas et al., 2019). 
Further studies would be necessary to test this hypothesis and to 
determine the extent to which the ecological and evolutionary driv-
ers of tumour suppressor gene expression observed in certain verte-
brates (i.e. elephants, see Abegglen et al., 2015) are also relevant in 
invertebrates. Currently, there is no empirical evidence for an exog-
enous initiator for any clonally transmissible cancers (Metzger et al., 
2016; Murchison et al., 2012, 2014; Stammnitz et al., 2018). A prom-
ising direction worth to explore in light of the increasing number 
of transmissible cancers (Metzger & Goff, 2016; Ujvari, Beckmann, 
et al., 2016; Ujvari Gatenby, & Thomas, 2016bb) is to determine the 
contribution of the immune system complexity to the emergence of 
contagious malignant cell lines and whether transmissible tumours 
have an immune cell originator.
2.2 | Indirectly transmissible cancers
There are several examples of indirectly transmissible cancers in 
nature that induce variable host immune responses and are com-
monly associated with infection by oncogenic pathogens, though 
additional initiating factors are often implicated in tumorigenesis. 
In Atlantic bottlenose dolphins (Tursiops truncatus) suffering from 
papillomavirus, there is systemic inflammation and an activated in-
nate immune response, with a partially activated adaptive immune 
response targeted against the virus rather than the tumour (Bossart 
et al., 2008; Rehtanz et al., 2010). Similarly, systemic inflammatory 
immune responses have been observed in green sea turtles (Chelonia 
mydas) suffering from virus-associated fibropapillomatosis alongside 
reduced lymphocyte proliferation, which may indicate immune ex-
haustion and a reduced capacity to raise an adaptive immune re-
sponse to the tumour or pathogen (Cray, Varella, Bossart, & Lutz, 
2001). A similar reduction of T-cell function has been demonstrated 
in Tasmanian devils following DFTD infection, suggesting that while 
the mode of avoiding T-cell recognition in DFTD is still not fully 
understood, there are similarities in certain immune evasion mech-
anisms (Cheng et al., 2019). In California sea lions (Zalophus califor-
nianus) suffering from Otarine herpes virus-1 (OtHV-1)-associated 
urogenital carcinoma (King et al., 2002), there is a strong correlation 
between environmental organochlorine contamination and cancer 
incidence despite equivalent OtHV-1 infection rates (Randhawa, 
Gulland, Ylitalo, DeLong, & Mazet, 2015). A link has also been dem-
onstrated between MHC diversity and cancer risk (Bowen et al., 
2005), indicating a genetic component to the disease that mirrors 
the emergence of directly transmissible tumours (Ujvari et al., 2018). 
The ceruminous gland tumours affecting the Santa Catalina Island 
fox (Urocyon littoralis catalinae) are associated with ear mite infesta-
tions, and a generalized systemic inflammatory environment caused 
by bite wounds combined with a specific immune response to ear 
mite infection is thought to encourage tumour formation (Moriarty 
et al., 2015; Vickers et al., 2015). Similar mechanisms have been sug-
gested in the emergence and transmission of facial tumours in the 
Tasmanian devil due to their aggressive social interactions (Hamede, 
McCallum, & Jones, 2013; Stammnitz et al., 2018).
The complex underlying causes of infectious cancers caused by 
pathogens often result in a systemic and nonspecific immune re-
sponse that is not protective, causing chronic infection and tumour 
persistence (Browning, Gulland, Hammond, Colegrove, & Hall, 2015; 
Moriarty et al., 2015). One common feature that may underpin the 
emergence of directly and indirectly transmissible cancers is low 
genetic diversity, as evidenced by Tasmanian devils (Siddle, Kreiss, 
et al., 2007), Santa Catalina Island foxes (Hofman et al., 2015) and 
California sea lions (Acevedo-Whitehouse, Gulland, Greig, & Amos, 
2003). However, many wild populations with extremely low genetic 
diversity thrive without increased cancer incidence (Weber, Stewart, 
Schienman, & Lehman, 2004), indicating that genetic diversity can-
not alone be causative and that more complex interactions may be 
responsible for carcinogenesis. Although strong associations exist 
between pathogens and indirectly transmissible tumours, most in-
fected individuals do not develop cancer, indicating that infection 
alone is not entirely the cause of tumour growth (Rehtanz et al., 
2010; Vickers et al., 2015).
Infectious cancers are the result of complex combinations of 
genetic susceptibility, pathogenic infections, and abiotic and be-
havioural factors that allow the emergence and transmission of tu-
mour cells or pathogens between individuals (i.e. the “perfect storm,” 
see Ujvari, Beckmann, et al., 2016; Ujvari Gatenby, & Thomas, 
2016aa). Understanding the interplay between these risk factors 
during the emergence and spread of cancers that are either caused 
by pathogens or by contagious cancer cell lines will not only help in 
managing current epidemics but also help to identify and manage 
emerging epidemics before they become widespread.
3  | ECOLOGIC AL ,  EPIDEMIOLOGIC AL AND 
E VOLUTIONARY DYNAMIC S OF C ANCERS 
IN WILDLIFE
Cancer emergence and progression do not occur in a vacuum, but 
rather in a complex suite of ecological and evolutionary interactions. 
In the same way that hosts can compensate for the fitness effects 
of parasitic infections (i.e. phenotypic plasticity of life-history traits), 
cancer is expected to trigger host responses to cope with the im-
munological and physiological demands of growing tumours. The 
diverse effects of cancer in host fitness (i.e. vulnerability to preda-
tion, susceptibility to coinfection with other pathogens, limited re-
productive output, reduced ability to disperse) often result in host 
responses and adaptive processes early in cancer development. 
6  |     HAMEDE Et Al.
For example, an experimental study demonstrated that drosophila 
(D. melanogaster) with induced colorectal cancer are able to adjust 
their life-history traits by reaching the peak of oviposition signifi-
cantly earlier that healthy ones (Arnal et al., 2017). Furthermore, 
there is evidence that the social environment of hosts can have a 
significant impact on cancer progression. Drosophila with induced 
colorectal cancer had faster tumour growth rates when kept in iso-
lation than did flies in control groups (Dawson et al., 2018). These 
responses demonstrate the intricate and dynamic relationships be-
tween hosts and oncogenic processes and the ability of hosts to 
trade off fitness costs at different stages of disease. Likewise, host 
social structure, behaviour and sexual selection have the potential to 
affect contact rates and hence the transmission of infectious cancers 
(Vittecoq et al., 2015). Environmental factors driving the emergence 
of cancers, whether from anthropogenic sources (e.g. carcinogenic 
pollutants,) or natural sources (e.g. viral oncogenes), suggest a con-
tinuum of interactions and selection between host and oncogenic 
processes. Furthermore, increasing evidence from genomic studies 
suggests that certain oncogenes are capable of mutating and jump-
ing hosts in species with disparate habitats and environmental at-
tributes (Cortes-Hinojosa et al., 2019; Literak et al., 2010).
The vast majority of deaths caused by cancer are related to me-
tastases, that is the development of secondary malignancies arising 
from the primary site of cancer in the host's body. However, meta-
static cancer is the endpoint of a much more complex process with 
several stages, ranging from precancerous lesions to localized estab-
lishment and disseminated growths (Vittecoq et al., 2013). In some 
circumstances, cancerous lesions might never metastasize, either 
because the hosts die from other causes or due to the development 
of defence mechanisms such as tolerance and resistance. While tol-
erance (the ability to reduce disease costs in host fitness) and resis-
tance (the ability to reduce disease burden or eliminate the disease) 
are mechanisms that have been mostly studied in host–parasite 
systems, there is now increasing evidence that these defence strat-
egies are also applicable to oncogenic phenomena (Margres et al., 
2018; Thomas et al., 2019). This is particularly relevant for transmis-
sible cancers, where malignant cell lines persist beyond the host's 
life expectancy and selective processes favour the development of 
coping strategies across generations. For example, Tasmanian devils 
affected by DFTD have developed tolerance to the tumours, with 
females being able to maintain body condition at significantly larger 
tumour volumes than males (Ruiz-Aravena et al., 2018). Additionally, 
survival after DFTD infection has increased significantly in long-term 
diseased areas (Wells et al., 2017). An example of resistance to can-
cer occurs in CTVT, which originated in a wild canid between 6,000 
and 10,000 years ago and currently affects domestic dogs (Baez-
Ortega et al., 2019; Murgia et al., 2006). Infected dogs are able to 
develop immune responses, causing tumour regression and recovery 
(Das & Das, 2000). Although CTVT may have been highly lethal early 
in its evolutionary history (see also Leathlobhair et al., 2018), it now 
coexists with its hosts (Strakova & Murchison, 2015). Coexistence 
between dogs and CTVT might be the result of continuous selec-
tive processes between the cancer cell line and hosts over millennia. 
However, the strong selective pressures of cancer can also operate 
on extremely short time scales. For example, a small proportion of 
Tasmanian devils have developed immune responses to DFTD re-
sulting in natural tumour regressions in as little as 8–10 years (4–5 
generations) after the cancer epidemic (Pye, Hamede, et al., 2016). 
The extremely high mortality of DFTD and the subsequent cata-
strophic population declines resulted in selection in regions of the 
genome that are associated with immune function and cancer risk 
(Epstein et al., 2016).
The high mortality caused by DFTD, where almost all individuals 
die within a year of attaining sexual maturity and their first mating 
event, would place strong selection pressure on life-history traits. 
In response to the cancer epidemic, a significant shift to younger 
populations and a 16-fold increase in the proportion of females 
able to breed in their first year (precocious sexual maturity) has 
been observed in several diseased sites (Jones et al., 2008; Lachish, 
McCallum, & Jones, 2009). Likewise, offspring sex ratios are more 
female-biased in diseased mothers compared to healthy mothers and 
litter size per female is significantly larger in populations where DFTD 
is present (Lachish et al., 2009; Lazenby et al., 2018). The rapid phe-
notypic and genotypic responses in the Tasmanian devil demonstrate 
that fast evolutionary processes in response to cancer can occur on 
ecologically relevant time scales. These processes can occur not just 
at the host level but also at the tumour level. Despite being a clonal 
cancer cell line, molecular studies have shown that DFTD is also sub-
ject to evolutionary plasticity (Murchison et al., 2012; Pearse et al., 
2012; Ujvari, Beckmann, et al., 2016; Ujvari Gatenby et al., 2016aa). 
More importantly, the evolutionary dynamics in the tumour can af-
fect individuals and populations in different contexts. As the DFTD 
epidemic unfolded, a sudden local replacement of tumour karyotype 
(from tetraploid to diploid) resulted in a significant increase of infec-
tion rates and population decline (Hamede et al., 2015). Observed 
differential growth rates between tetraploid and diploid tumours 
(Hamede, Beeton, Carver, & Jones, 2017) may also select for poly-
morphism in tumour virulence. This may provide scope for an evolu-
tionary arms race between cancer cells and hosts. At the host level, a 
broad range of eco-immunological dynamics such as seasonal dynam-
ics of stress, demographic variation in immune expression profiles, 
reproductive hormones and immune senescence, as well as genetic 
and phenotypic variation, may interact with cancer susceptibility and 
tumour progression. At the tumour level, selection should favour lin-
eages that reach optimal virulence, a trade-off between transmission 
rate and disease-induced mortality (Ebert & Bull, 2003).
The Tasmanian devil–DFTD system provides a unique oppor-
tunity to understand the interplay of ecological, evolutionary and 
epidemiological dynamics in response to cancer (Figure 1). Both tu-
mours and devils have been consistently studied at multiple scales 
across the species' distributional range since the beginning of the 
epidemic. The observed selection and eco-evolutionary dynamics in 
DFTD should be used as a benchmark for studying and managing 
DFT2, for which limited information exists (James et al., 2019). More 
importantly, this knowledge could allow the use of several model-
ling approaches to predict the evolutionary trajectory of malignant 
     |  7HAMEDE Et Al.
cells as well as evaluating critical epidemiological parameters such 
as tumour virulence, host susceptibility and tolerance/resistance to 
infection.
4  | FOLLOWING THE C ANCER FOOTPRINT: 
FROM SPECIES CONSERVATION TO 
ECOSYSTEM FUNC TION
Cancer may be of particular concern in the small population paradigm 
in conservation, where stochastic causes of mortality can present a 
significant threat. Small populations or threatened species with low 
genetic diversity might be more susceptible to cancer (Ujvari et al., 
2018). Population-level effects of cancer, such as reduction in popu-
lation growth rate and cascading effects flowing through commu-
nity and ecosystem levels, can be difficult to document. Establishing 
causal links between population decline and oncogenic processes in 
wildlife is fraught with the difficulties of long-term investigation and 
establishing the cause of mortalities in a sufficient proportion of the 
population. The clearest and best documented case of population 
decline caused by cancer is the Tasmanian devil–DFTD system (see 
Box 1).
Genetically isolated populations or those affected by other 
threatening processes can become more susceptible to cancer or 
mutagenic agents. For example, the critically endangered Santa 
Catalina Island fox neared extinction from hyperpredation by native 
eagles facilitated by abundant feral pigs (Roemer, Coonan, Garcelon, 
Bascompte, & Laughrin, 2001). Santa Catalina island foxes are also 
highly susceptible to exotic diseases (Crooks, Scott, & Vuren, 2001) 
and to ceruminous gland tumours, for which chronic inflammation 
from bacterial and mite infestation may promote tumorigenesis 
(Vickers et al., 2015). The genetic distinctiveness of this subspecies 
may predispose it to cancer: it has one of the highest rates of can-
cer observed in a wild population (Vickers et al., 2015). In further 
examples, debilitation by oncogenic viruses and tumour-associated 
mortality limit population growth in small, isolated island popula-
tions of the western barred bandicoot (Perameles bouganville) and in 
a small population of Attwater's subspecies of the prairie chicken 
(Tympanuchus cupido attwateri) (McAloose & Newton, 2009). The 
prevalence of herpes virus-associated fibropapillomatosis is increas-
ing in sea turtles, particularly in green sea turtles along the coasts 
of Florida and the Caribbean and Hawaiian Islands; it is considered 
to be a contributing factor to the ongoing population decline in 
these endangered species. Evidence of tumour regression offers a 
pathway for recovery (Guimarães, Gitirana, Wanderley, Monteiro-
Neto, & Lobo-Hajdu, 2013; Tagliolatto, Guimarães, Lobo-Hajdu, & 
Monteiro-Neto, 2016) and potentially the evolution of resistance, as 
is occurring in Tasmanian devils (Epstein et al., 2016; Margres et al., 
2018).
Documented evidence of trophic cascades triggered by can-
cer-induced population decline is rare and often not known 
(e.g. Santa Catalina Island fox; Vickers et al., 2015). Again, the 
Tasmanian devil–DFTD host–pathogen system provides the clear-
est and best documented case study. The progressive spatial and 
temporal patterns of devil population decline as DFTD has spread 
from east to west across the island state provide a rare natural 
experiment on the influential top-down role of this apex preda-
tor and primary scavenger in structuring Tasmanian ecosystems 
(Hollings, Jones, Mooney, & McCallum, 2014, 2016). The decline 
in devil populations has released invasive mesopredators from 
competition, with cascading effects on the decline in populations 
of small native mammals (Hollings, Jones, Mooney, & McCallum, 
2016). Introduced pest species such feral cats (Felis catus) and 
black rats (Rattus rattus) have increased in abundance (Cunningham 
et al., 2018). While the native mesopredator, the spotted-tailed 
quoll (Dasyurus maculatus), relax their temporal avoidance of dev-
ils when devils are at low density (Cunningham, Scoleri, Johnson, 
Barmuta, & Jones, 2019), it is possible that competition with the 
similar-sized feral cat, which has a higher fecundity (two rather 
than one litter per year), may counter the competitive release 
F I G U R E  1   The Tasmanian devil and 
its transmissible tumour (DFTD), an 
ideal model system to understand how 
species adapt and evolve in response 
to infectious cancers and study the 
interplay of ecological, evolutionary and 
epidemiological processes. Blue boxes 
represent host and tumour parameters 
under selection through evolutionary 
interactions (red arrows). Host tolerance 
and resistance and tumour morbidity and 
virulence are under selection through 
ecological and evolutionary interactions. 
These interactions feed back into 
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from devils. Cats may be holding the smaller native mesopredator, 
the eastern quoll (Dasyurus viverrinus), in a “predator pit” where 
cats are at high density. Devil decline may also trigger a disease 
cascade, as the increased numbers of cats have been associated 
with a higher seroprevalence of Toxoplasma gondii in Tasmanian 
herbivores (Hollings, Jones, Mooney, & McCallum, 2013). These 
processes at the species and ecosystem levels highlight the broad-
scale effects of cancer in wildlife and the vital need to document 
and study its implications for ecosystem functioning.
5  | APPLIC ATIONS FOR MANAGEMENT 
AND CONSERVATION
Studies of cancer in wildlife have been mostly accidental and reactive. 
There has been a historical lack of consistency in studying tumorigen-
esis across species and monitoring the broad-scale effects of cancer in 
wildlife. With few exceptions, such as Tasmanian devils and DFTD and 
CTVT in dogs, most studies are limited to a few postmortem examina-
tions. In addition, many oncoviruses are asymptomatic and difficult to 
diagnose, making the epidemiological efforts needed to detect cancer 
in wildlife even more challenging. The discovery of eight transmissible 
cancers in the last 25 years (two in Tasmanian devils and six in marine 
bivalves) suggests that (a) some species/environments might be par-
ticularly susceptible to these type of cancers, (b) there is a relationship 
between environmental change/disturbance and emergence of trans-
missible cancers or (c) transmissible cancers may have been more com-
mon throughout the evolutionary history of multicellular species, but 
our ability to detect them has only recently improved due to advances 
in biotechnology and multidisciplinary efforts in surveying populations. 
Furthermore, while multicellular organisms have been exposed to on-
cogenic phenomena throughout their evolutionary history, sudden 
changes in ecological and environmental conditions may result in a mis-
match, promoting the development of cancers in the wild. Experimental 
studies in model systems can be a valuable tool to further understand 
mechanisms of selection and fitness costs associated with oncogenesis 
and tumour progression (i.e. Dawson et al., 2018).
Expanding the range and scope of studies on wildlife cancer is 
necessary to increase our ability to undertake comparative research 
at the human–wildlife–domestic interface and their environments. 
Robust data sets are key to further the development of fields such 
as comparative oncology and to understanding the prognosis, re-
sponses and survival in a broad range of malignancies across tissues, 
individuals, populations and species. Contrasting the biology and 
evolutionary ecology of tumours across species will provide a new 
perspective for understanding patterns of carcinogenesis and help 
Box 1. The birth, spread and impact of transmissible cancers in Tasmanian devils
First detected in 1996 in northeast Tasmania, DFTD has spread across most of the distributional range of the devil in Tasmania 
(Figure 2; Hawkins et al., 2006; Lazenby et al., 2018). Clearly visible primary tumours (Loh et al., 2006), high recapture probability in 
trapping surveys (Lachish, Jones, & McCallum, 2007), and a concerted field monitoring and research effort have enabled clear causal 
links between DFTD spread, population decline and cascading effects at the ecosystem level to be established (Lazenby et al., 2018; 
McCallum et al., 2007).
Devil population decline accelerates 3 years after local disease emergence because the infection increases exponentially (McCallum 
et al., 2009), reaching a 60% decline after 5–6 years and up to a 90% decline in some areas (Lachish et al., 2007; McCallum et al., 
2007). The rapid population decline led to the species being listed as Endangered at the international (IUCN Red List), national and 
state levels (Hawkins, McCallum, Mooney, Jones, & Holdsworth, 2009). Strong frequency-dependent transmission, likely caused by 
biting during the mating season, also contributed to concerns of extinction as a possible outcome of the epidemic (McCallum et al., 
2009). However, to date, no local extinctions have been reported and long-term diseased populations persist despite high prevalence 
of tumours (Hamede et al., 2015; Lazenby et al., 2018). The rapid evolutionary response of devils to DFTD (within 4–6 generations) 
indicates that the adaptive shift is operating on the genetic variation present prior to the DFTD epidemic (Epstein et al., 2016), de-
spite the low genetic diversity (Jones, Paetkau, Geffen, & Moritz, 2004; Siddle, Marzec, Cheng, Jones, & Belov, 2010) resulting from 
population bottlenecks during the last glacial maximum and during the Holocene (Brüniche-Olsen, Jones, Austin, Burridge, & Holland, 
2014).
In 2014, a second and independently evolved transmissible cancer (DFT2) was discovered at the d'Entrecasteaux peninsula in south-
eastern Tasmania. DFT2 and DFTD coexist in the same population, and a limited number cases of coinfection (both diseases in the 
same individual) have been reported (Kwon et al., 2018). Both tumours have been reported to be of neuroectodermal origin and 
most likely evolved from devils in north-eastern and south-eastern Tasmania (Stammnitz et al., 2018; Storfer et al., 2018). So far, 
DFT2 seems to be confined to the peninsula where it was first reported, although monitoring efforts outside of the peninsula have 
been limited (James et al., 2019). The population response to DFT2 and the epidemiological, ecological and evolutionary interactions 
between devils and DFTD are currently unknown; however, competition and selective processes are expected to occur at individual 
and population levels. In that sense, current and future research will be vital to predict epidemiological and evolutionary dynamics in 
the devil/DFTD/DFT2 study system.
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mitigate risks of cancer emergence in the wild. We therefore suggest 
using a three-level approach to the study of wildlife cancer that will 
provide a solid link between fundamental research in cancer biology, 
eco-evolutionary processes and management and conservation.
First, increased networking and collaborative studies between 
disease ecologists and cancer biologists would maximize the capacity 
to diagnose cancer in the wild (Dujon et al. submitted to this Special 
Issue). A growing number of wildlife, human and environmental health 
surveys are undertaken globally at multiple scales, and initiatives such 
as One Health and Conservation Medicine are providing a practical link 
for disciplines that previously worked in isolation. This provides an 
ideal scenario for coordinating and expanding cancer surveillance at 
the ecosystem level. In parallel, new technologies and promising bio-
markers for neoplasia are becoming valuable cost-effective diagnostic 
tools for monitoring cancer prevalence in captive and wild popula-
tions (Gourlan, Douay, & Telouk, 2019; Kourou, Exarchos, Exarchos, 
Karamouzis, & Fotiadis, 2015). The combination of technologies, co-
ordination of surveys and diagnostic capacity offers a new platform 
to detect cancer in the wild, which will improve our ability to swiftly 
respond to epizootics and collect critical data.
Second, expertise should be drawn from different disciplines 
by integrating cancer research in humans, domestic species and 
wildlife populations to understand cellular, organismal and environ-
mental mechanisms of carcinogenesis and their epidemiological and 
evolutionary patterns. While evolutionary biology and ecology are 
disciplines that have been recently integrated into oncology, the 
relevance of eco-evolutionary processes for recognizing cancer as 
an important agent of selection remains to be developed and in-
tegrated into wildlife management and conservation. For example, 
evolutionary principles can be used for disentangling within- and 
between-host dynamics and trade-offs in response to cancer. 
Evaluating the role of infectious cancers as important agents of se-
lection across populations provides a holistic and adaptive frame-
work for understanding the adaptive capabilities of different species 
in response to oncogenic processes (Russell et al., 2018). The inte-
gration of these disciplines will also help to disentangle the biolog-
ical/environmental mechanisms of cancer emergence and evaluate 
the diversity and lethality of tumours across taxa.
Finally, the knowledge generated from the cross-discipline 
framework should be used to develop adaptive management strat-
egies and general guidelines in response to infectious cancers in 
wildlife. For example, understanding the long-term effects of the 
DFTD epidemic in Tasmanian devils—from its devastating popula-
tion declines to the resulting functional changes in the genome—is 
critical for evaluating the extent to which management interven-
tions are required. On the one hand, wildlife managers working 
with threatened wildlife are often focused on maximizing genetic 
diversity and reducing inbreeding (i.e. genetic rescue). On the 
other hand, modern genomic techniques have recently allowed the 
identification of adaptive genetic variation in response to drastic 
threatening processes such as disease epidemics or environmental 
degradations. The notion that rapid evolutionary changes in re-
sponse to emerging infectious diseases can result in highly adapted 
genotypes and phenotypes by natural selection has given rise to the 
hope that populations in dire decline can be rescued through evo-
lution (i.e. evolutionary rescue; Carlson, Cunningham, & Westley, 
2014; DiRenzo et al., 2018). The adaptive capacity of Tasmanian 
devils in response to DFTD at different spatial and temporal scales 
(Epstein et al., 2016; Hamede, McCallum, & Jones, 2019) suggests 
that eco-evolutionary processes need to be thoroughly considered 
by wildlife managers and that rigorous evaluation of host–tumour 
interactions should be a priority to improve the conservation pros-
pects of species in the face of epidemics (Hohenlohe et al., 2019).
The holistic vision proposed here is particularly relevant for 
most species affected by infectious cancers. The eradication of in-
fectious cancers is not usually a plausible outcome; therefore, ad-
aptations to these oncogenic processes are likely to evolve. Given 
the rapid environmental changes we are facing globally, the car-
cinogenic contaminants circulating in natural habitats and the in-
creasing overlap among human, domestic and wildlife populations, 
greater attention should be given to screening for the development 
of neoplastic diseases across species and environments. In this 
sense, wildlife cancer can act a sentinel of environmental distur-
bance and species susceptibility to other threatening processes.
6  | CONCLUDING REMARKS
Much of the historical understanding of cancer has come from 
studies of human tumours and experimental research in labora-
tory mice. Because of this, cancer was until recently perceived as 
an evolutionary dead end. Studies in wildlife are now providing 
F I G U R E  2   Map of Tasmanians showing the emergence and 
progression of two transmissible cancers in Tasmanian devils. While 
DFTD has spread from east to west over the last 25 years (dashed 












10  |     HAMEDE Et Al.
novel perspectives for understanding eco-evolutionary processes 
at the cellular and organismal levels. As we look towards the fu-
ture, there is a unique opportunity to integrate human, experi-
mental and animal cancer research. The examples provided here 
highlight that cancer in wildlife is the result of a diverse range of 
mechanisms, including the emergence of novel cancer cell lines 
able to result in allograft transmission, an increasing number of 
virus-associated oncogenes, environmental change and carcino-
genic pollutants. The pervasive nature of cancer in wildlife opens 
the field for studying the genesis of malignant cells, coping mech-
anisms at the individual level and transgenerational adaptations 
at the population level. Understanding how species respond and 
adapt to oncogenic processes and the trade-offs of suppressing 
malignant cell growth at the interface of environmental, ecologi-
cal and evolutionary burdens should become a priority for on-
cologists, evolutionary biologists, disease ecologists and wildlife 
managers.
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